378 related articles for article (PubMed ID: 24014238)
21. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
22. CD40 activation: potential for specific immunotherapy in B-CLL.
von Bergwelt-Baildon M; Maecker B; Schultze J; Gribben JG
Ann Oncol; 2004 Jun; 15(6):853-7. PubMed ID: 15151939
[TBL] [Abstract][Full Text] [Related]
23. Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.
Mayr C; Kofler DM; Büning H; Bund D; Hallek M; Wendtner CM
Blood; 2005 Nov; 106(9):3223-6. PubMed ID: 16014560
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
25. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
26. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
[TBL] [Abstract][Full Text] [Related]
27. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis.
Wagner DH; Stout RD; Suttles J
Eur J Immunol; 1994 Dec; 24(12):3148-54. PubMed ID: 7528671
[TBL] [Abstract][Full Text] [Related]
28. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.
Brines RD; Klaus GG
Int Immunol; 1993 Nov; 5(11):1445-50. PubMed ID: 7505108
[TBL] [Abstract][Full Text] [Related]
29. GIFT4 fusokine converts leukemic B cells into immune helper cells.
Deng J; Pennati A; Cohen JB; Wu Y; Ng S; Wu JH; Flowers CR; Galipeau J
J Transl Med; 2016 Apr; 14(1):106. PubMed ID: 27118475
[TBL] [Abstract][Full Text] [Related]
30. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
31. T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent
Lopez-Ocasio M; Buszko M; Blain M; Wang K; Shevach EM
Front Immunol; 2020; 11():637. PubMed ID: 32362895
[TBL] [Abstract][Full Text] [Related]
32. In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins.
Fujiwara H; Melenhorst JJ; El Ouriaghli F; Kajigaya S; Grube M; Sconocchia G; Rezvani K; Price DA; Hensel NF; Douek DC; Barrett AJ
Clin Cancer Res; 2005 Jun; 11(12):4495-503. PubMed ID: 15958635
[TBL] [Abstract][Full Text] [Related]
33. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
Ranheim EA; Kipps TJ
J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
[TBL] [Abstract][Full Text] [Related]
34. Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.
Nova-Lamperti E; Chana P; Mobillo P; Runglall M; Kamra Y; McGregor R; Lord GM; Lechler RI; Lombardi G; Hernandez-Fuentes MP;
Transplantation; 2017 Mar; 101(3):541-547. PubMed ID: 27472092
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.
Schattner EJ; Mascarenhas J; Reyfman I; Koshy M; Woo C; Friedman SM; Crow MK
Blood; 1998 Apr; 91(8):2689-97. PubMed ID: 9531577
[TBL] [Abstract][Full Text] [Related]
36. HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia.
Tolba KA; Bowers WJ; Eling DJ; Casey AE; Kipps TJ; Federoff HJ; Rosenblatt JD
Mol Ther; 2002 Oct; 6(4):455-63. PubMed ID: 12377186
[TBL] [Abstract][Full Text] [Related]
37. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
38. Functions of CD40 and Its Ligand, gp39 (CD40L).
Laman JD; Claassen E; Noelle RJ
Crit Rev Immunol; 2017; 37(2-6):371-420. PubMed ID: 29773027
[TBL] [Abstract][Full Text] [Related]
39. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.
Sia JK; Bizzell E; Madan-Lala R; Rengarajan J
PLoS Pathog; 2017 Aug; 13(8):e1006530. PubMed ID: 28767735
[TBL] [Abstract][Full Text] [Related]
40. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]